Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FourthWall Testing was a private clinical testing laboratory launched by Epitome Risk to provide COVID-19 diagnostic and immune-response testing services. The business focused on rapid antigen testing, PCR testing, neutralizing antibody testing, and related immune assessment services for consumers, businesses, and film/TV productions. Public materials describe the lab as serving the Atlanta area with 24/7 operations during the COVID-19 era and supporting direct-to-consumer and workplace testing workflows. Available evidence suggests it was a service laboratory rather than a therapeutic biotech developer, with no disclosed drug pipeline or clinical development programs. Corporate registry and directory traces indicate the entity is no longer clearly operating as an active standalone company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FourthWall Testing.